1144 related articles for article (PubMed ID: 29563797)
21. Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies.
Habault J; Poyet JL
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866424
[TBL] [Abstract][Full Text] [Related]
22. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
23. Advance of DNA and CCPs-based nanocarriers in drug delivery systems.
Wu Y; Yao X; Chen Y; Li Y; Tian W
Biomed Mater Eng; 2017; 28(s1):S255-S261. PubMed ID: 28372302
[TBL] [Abstract][Full Text] [Related]
24. Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.
MacEwan SR; Chilkoti A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):31-48. PubMed ID: 22977001
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
26. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
[TBL] [Abstract][Full Text] [Related]
27. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
28. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
Mei L; Zhang Q; Yang Y; He Q; Gao H
Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
[TBL] [Abstract][Full Text] [Related]
29. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
30. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
[TBL] [Abstract][Full Text] [Related]
31. Lipid-Based Nanoparticle Functionalization with Coiled-Coil Peptides for
Aschmann D; Knol RA; Kros A
Acc Chem Res; 2024 Apr; 57(8):1098-1110. PubMed ID: 38530194
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
Ang CY; Tan SY; Zhao Y
Org Biomol Chem; 2014 Jul; 12(27):4776-806. PubMed ID: 24737243
[TBL] [Abstract][Full Text] [Related]
33. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
[TBL] [Abstract][Full Text] [Related]
34. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.
Borrelli A; Tornesello AL; Tornesello ML; Buonaguro FM
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385037
[TBL] [Abstract][Full Text] [Related]
35. Cell-penetrating peptides: design, synthesis, and applications.
Copolovici DM; Langel K; Eriste E; Langel Ü
ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
[TBL] [Abstract][Full Text] [Related]
36. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
[TBL] [Abstract][Full Text] [Related]
37. Peptide cargo administration: current state and applications.
Rohira H; Arora A; Kaur P; Chugh A
Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
[TBL] [Abstract][Full Text] [Related]
38. Cell penetrating peptides for tumor targeting.
Choi YS; Lee JY; Suh JS; Lee SJ; Yang VC; Chung CP; Park YJ
Curr Pharm Biotechnol; 2011 Aug; 12(8):1166-82. PubMed ID: 21470141
[TBL] [Abstract][Full Text] [Related]
39. [The development of cell-penetrating peptides in drug delivery system].
Fan B; Jin MJ; Huang W; Wang QM; Gao ZG
Yao Xue Xue Bao; 2016 Feb; 51(2):264-71. PubMed ID: 29856580
[TBL] [Abstract][Full Text] [Related]
40. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
